This transaction
Acquisition of Shares in Globizz Corporation and Other Companies (Making Them Subsidiaries)The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Support for US FDA submissions and registrations, support for expansion into Europe and Asia, and sales of medical devices in the United States
| Item | Details |
|---|---|
| Transaction name | Acquisition of Shares in Globizz Corporation and Other Companies (Making Them Subsidiaries) |
| Name of the Subject Company | Globizz Corporation and Other Companies (Globizz Corp. / 株式会社グロービッツ・ジャパン and 2 other companies) |
| Business Description of the Subject Company | Support for US FDA submissions and registrations, support for expansion into Europe and Asia, and sales of medical devices in the United States |
| Location of the Subject Company | Los Angeles, California, United States (US headquarters) |
| Voting rights ownership percentage | After 100％ (before not disclosed) |
| Execution Date / Effective Date | Effective 14 October 2026 (made a wholly owned subsidiary) |
Items this document does not state (26)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To advance efforts to enter the US market, introduce cutting-edge products into the Company’s product lineup, incorporate specialist capabilities such as FDA submissions and registrations, leverage bases in the United States, South Korea, India and elsewhere, and secure new revenue opportunities in the consulting business, with a view to achieving overseas sales of ¥10 billion under the “10-Year Vision.”